(Total Views: 852)
Posted On: 08/26/2020 11:51:46 PM
Post# of 149459
I think convalescent plasma backfired and looked only political and Dr. Hahn should resign. Another approval now is really needed for a real political gain that they were looking for but does Leronlimab have the statistics to look like a breakthrough? Maybe? Maybe it’s just a functional therapeutic that works really good. Maybe it is saving lives and the trial to show that is the severe to critical. Maybe the safety
look we had started something behind the scenes? They just told Cytodyn to go into stealth mode. Minimal exposure and Nader had to call Trumps OWS group to defend the company against these two lousy articles today?
Best case scenario:
This past few weeks since we had the safety look and they told us that we should continue the trial. What if... OWS told Nader to say that and started the process to increase manufacturing even if it takes other manufacturers to be approved before announcing a EUA. It’s all about getting your ducks in a row before you announce a drug that saves lives but we can only save 250-300 thousand critical and or mild to moderate patients this year and maybe not even helping the mild to moderate because Critical patients need it more and lives are at stake. We have to massively upscale production in order to be relevant. That’s what OWS was intended to do. The deals could of been made a week or two ago and now just waiting to get another deal with licensing/ partnership with a big pharmaceutical. If all that was true. Then yes! It could be us tomorrow that gets announced for EUA. A lot of behind the scenes will have had to have happened. If that best case scenario didn’t actually happen We won’t be in the news tomorrow. I don’t believe any other therapeutic is ready for a EUA. So if not us then nobody.
look we had started something behind the scenes? They just told Cytodyn to go into stealth mode. Minimal exposure and Nader had to call Trumps OWS group to defend the company against these two lousy articles today?
Best case scenario:
This past few weeks since we had the safety look and they told us that we should continue the trial. What if... OWS told Nader to say that and started the process to increase manufacturing even if it takes other manufacturers to be approved before announcing a EUA. It’s all about getting your ducks in a row before you announce a drug that saves lives but we can only save 250-300 thousand critical and or mild to moderate patients this year and maybe not even helping the mild to moderate because Critical patients need it more and lives are at stake. We have to massively upscale production in order to be relevant. That’s what OWS was intended to do. The deals could of been made a week or two ago and now just waiting to get another deal with licensing/ partnership with a big pharmaceutical. If all that was true. Then yes! It could be us tomorrow that gets announced for EUA. A lot of behind the scenes will have had to have happened. If that best case scenario didn’t actually happen We won’t be in the news tomorrow. I don’t believe any other therapeutic is ready for a EUA. So if not us then nobody.
(6)
(0)Scroll down for more posts ▼
